- You can view the full Baxter International Ratings Report.
- Use our health services section to find industry-relevant news.
- Or find some new ideas from our top rated stocks lists.
- Find other investment ideas from our top rated ETFs lists.
By acquiring Claris, Baxter expects to launch seven to nine new generic injectable medicines each year over the next several years.